⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Julie Kanter WashkoMD

Hematology-Oncology · Birmingham, AL 35233

NPI: 1902071368

Share:𝕏fin

40

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers95th percentile opioid prescribingElevated cost per beneficiary

Risk indicators are statistical patterns, not allegations. Learn more

3,580

Total Claims

$5.2M

Drug Cost

196

Beneficiaries

$26K

Cost/Patient

Risk Score Breakdown 40/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+10
Cost per patient outlier+3

Score components are additive. Read full methodology

Peer Comparison vs. 8,541 Hematology-Oncology providers

+652%

Opioid rate vs peers

47.2% vs 6.3% avg

+93%

Cost per patient vs peers

$26K vs $14K avg

-4%

Brand preference vs peers

14.0% vs 14.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

Opioid Prescribing

47.2%

Opioid Rate

1,688

Opioid Claims

$55K

Opioid Cost

28.9%

Long-Acting Rate

This provider's opioid prescribing rate of 47.2% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

86% generic

Brand: 500 claims · $3.0M

Generic: 3,080 claims · $2.1M

Patient Profile

42

Avg Age

61%

Female

4.46

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About